Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received two suspension orders for drug licenses from the Drugs Control Administration in Karnataka. The first order suspends the license for three days for a store at Kalidasa Layout, with a potential revenue loss of Rs 0.64 lakhs. The second order suspends the license for two days for a store at Mg Road, Chikkamagaluru, with a potential revenue loss of Rs 2.07 lakhs. Both orders were received on May 11, 2026, and relate to violations under the Drugs and Cosmetics Act, 1940 and Rules, 1945. The combined potential revenue impact is Rs 2.71 lakhs.
The financial impact is minimal at around Rs 2.71 lakhs, but the suspension of drug licenses for retail pharmacy stores could temporarily affect store operations and reputation in Karnataka. Shareholders should monitor for any further regulatory actions.